news aktuell GmbHnews aktuell GmbH

BrainRepair UG: Investment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns

Share

Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M

(Bochum, Germany): One of the most successful inventors and entrepreneurs who masterminded the unprecedented success of Qiagen N.V. from a start-up to a 10 billion market cap enterprise has taken the decision to refocus his activities on BrainRepair UG, a spin-off of the Ruhr-University Bochum (RUB). BrainRepair UG has developed a unique method based on own (autologous) cord blood stem cells to treat brain damage and cerebral palsy (CP) in newborns affecting 70,000 babies in the EU each year. Metin Colpan’s patented invention has become a standard method recommended by the World Health Organization (WHO) and is used by researchers all over the world, changing the way they can access, purify and understand genetic data in DNA and RNA. The European Patent Office states “…The tireless work of German scientist Metin Colpan over four decades has paved the way for rapid and effective genetic data analysis, enabling researchers to better detect disease and unlocking new therapies for conditions, including COVID-19,” and Prof. Dr. Arne Jensen, Co-Founder and CEO of BrainRepair UG, continues “We are delighted that we now can draw on the vast experience Dr. Colpan is offering us as Member of the Board of Directors and Chairman of the Advisory Board on our way to the stock market at Nasdaq First North for which the IPO is planned in November 2021.” BrainRepair UG’s stem cell product has been granted the worldwide first ‘Orphan Drug Designation’ (ODD) by the European Commission and the European Medicines Agency. This designation guarantees market exclusivity in all EU member states for 12 years upon market authorisation. Prof. Arne Jensen stresses, “All our personal, scientific, clinical, and philanthropic efforts serve the ultimate goal – to combat infantile Cerebral palsy, the most common disability in childhood, and stop CP in children!”

About Qiagen N.V.
QIAGEN is a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding QIAGEN N.V., the company operates more than 35 offices in over 25 countries.[16] QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer. The main operative headquarters are located in Hilden, Germany. Number of employees: about 5,000. Total equity: US $2,634.970 million. Industry: Biotechnology. Total assets: US $5,748.332 million. Market capitalization: US $ 11,123 billion.

About BrainRepair UG
BrainRepair UG is a clinical stage start-up developing cutting edge stem cell treatments based on human cord blood for a wide range of indications related to brain injury in children including those caused by oxygen lack and inflammation (PVL, HIE, NE), hemorrhage, stroke, cerebral palsy (CP), traumatic brain injury (TBI), and spinal cord injury (SCI). BrainRepair UG is the first Biotech company worldwide whose stem cell products have been awarded ‘Orphan Medicinal Product Designations’ for the treatment of brain injury in newborn infants (PVL, NE) by the European Commission and the European Medicines Agency, EMA. BrainRepair’s Headquarter is in Bochum, Germany. You may visit the website at https://brainrepair.eu/ for more information.

Links:
Metin Colpan (DE) - Finalist for the European Inventor Award 2021 – EPO https://www.epo.org/news-events/events/european-inventor/finalists/2021/colpan.html

Autologous Cord Blood Therapy for Infantile Cerebral Palsy: From Bench to Bedside,Obstet Gynecol Int vol.2014,12p; https://www.hindawi.com/journals/ogi/2014/976321/

First Autologous Cord Blood Therapy for Pediatric Ischemic Stroke and Cerebral Palsy Caused by Cephalic Molding during Birth: Individual Treatment with Mononuclear Cells", Case Reports in Transplantation, vol. 2016, Article ID 1717426, 9 pages, 2016. https://www.hindawi.com/journals/crit/2016/1717426/

EMA Orphan medicinal Product Designation Periventricular leukomalacia (PVL): https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3161744

EMA Orphan medicinal Product Designation Newborn encephalopathy (NE): https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3161743

Contacts

BrainRepair UG (haftungsbeschränkt)
Prof. Dr. med. Arne Jensen, MD, MBA
Ruhr-University Bochum
Campus Clinic Gynaecology
Universitätsstr. 136
44799 Bochum, Germany
Tel.: +49 234 588 196-0
Fax.: +49 234 588 196-19
Email: arne.jensen@brainrepair.eu

Images

Dr. Metin Coplan, Founder and long-term CEO of Qiagen N.V. and Finalist of the EPO European Inventor Award 2021
Dr. Metin Coplan, Founder and long-term CEO of Qiagen N.V. and Finalist of the EPO European Inventor Award 2021
Download

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

CUSTOMCELLS®: Cellforce Group GmbH: Joint Venture between Porsche and CUSTOMCELLS21.6.2021 13:46:49 CEST | Press release

(Germany - Stuttgart / Tuebingen / Itzehoe): The latest step in the electric offensive: Porsche is investing a high double-digit million amount in the new company Cellforce Group GmbH. Porsche and joint venture partner CUSTOMCELLS today announced the launch of production of high-performance battery cells at the Weissach Development Centre. CUSTOMCELLS is one of the world’s leading companies in the development of special lithium-ion battery cells. “The battery cell is the combustion chamber of the future. As a new Porsche subsidiary, the Cellforce Group will be instrumental in driving forward the research, development, production and sales of high-performance battery cells,” says Oliver Blume, Chairman of the Executive Board at Porsche. “This joint venture allows us to position ourselves at the forefront of global competition in developing the most powerful battery cell and make it the link between the unmistakable Porsche driving experience and sustainability. This is how we shape the

Framo GmbH: Framo on a clear course: New investments of 15 million euros, market presence strengthened17.6.2021 08:15:00 CEST | Press release

Top meeting of Framo GmbH, Löbichau: Investor and main shareholder Majed Al-Askar announces high investments With 5 million euros in the current fiscal year 2021 and a further 10 million euros in 2022, the Saxon eTruck designers and retrofitters are once again committing to future markets Research, development and battery production to be significantly expanded (Löbichau): After a top management meeting, Saxon eTruck builder and retrofitter Framo reaffirms its role as a specialized industry shaper: "We will increase investment volume by 5 million euros before the end of the current fiscal year, with another 10 million euros to follow as early as 2022," says Majed Al-Askar, principal shareholder and investor in Framo GmbH. "We will continue to play a key role in shaping the market for emission-free heavy-duty transport." New perspectives after change in management "In the past and with the previous management, unfortunately, not everything went consistently smooth," says Al-Askar. "But

China-CEEC Expo: The 2nd China-CEEC Expo and International Consumer Goods Fair closed successfully14.6.2021 13:59:42 CEST | Press release

(Ningbo, China): Insisting on the theme of "Fostering a New Development Paradigm, Sharing a Win-Win Opportunity," the Second China-Central and Eastern European Countries (CEEC) Expo and International Consumer Goods Fair, co-organized by the Ministry of Commerce of China and the People's Government of Zhejiang Province, and jointly undertaken by the People's Government of Ningbo, Zhejiang Provincial Department of Commerce and the Trade Development Bureau of the Ministry of Commerce, concluded in Ningbo of East China's Zhejiang Province on June 11. Chinese President Xi Jinping sent a congratulatory letter to the expo, and Vice Premier Hu Chunhua delivered a speech at the opening ceremony. Serbia and Czech Republic are the expo’s countries of honor. Affected by the pandemic, international VIPs attended the forum in two forms: online speeches by dignitaries + offline visits by envoys. Two presidents and six deputy premiers/ministers from the countries of honor gave online speeches, express

BMW Group: The BMW Group announces global partnership with the Bayerische Staatsoper. Expansion of long-term partnership is a contribution to social responsibility efforts and provides new impulses for the renowned Munich opera house8.6.2021 14:35:52 CEST | Press release

(Munich, Germany): Marking the year of the 50th anniversary of cultural commitment, the BMW Group is building up on its cooperation with the Bayerische Staatsoper by becoming the Global Partner. The automotive manufacturer and the opera house have been partners since 1997. On the occasion of their 25th anniversary and with Serge Dorny as designated General Manager and Vladimir Jurowski as designated General Music Director, collaborations such as Opera for all will continue while also focussing on the development of digital formats to reach a broader audience. The BMW Group leads the way as corporate citizen and contributes to social responsibility. As one of the world’s leading opera houses, the Bayerische Staatsoper looks back on a history of over 350 years and makes a major contribution to Munich’s reputation as one of the great international cultural capitals. In 1997, BMW and the Bayerische Staatsoper initiated Opera for all including the live broadcast of an opera and the open-air

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom